John A DeFord
CIK 1403373 · Sr. VP Sci Tech and Clin Afrs · last filed 2026-08-03
John A DeFord is a Sr. VP Sci Tech and Clin Afrs who has filed 99 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing shows the insider was granted $25.0K of NDSN on Aug 3, 2026. Across all open-market trades the lifetime net is +$100.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.41M
4
99
$100.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NDSN | Director | 5,902 | $308.69 | $1.82M | $0 | 18 | 2026-08-03 |
| MRVI | Director | 205,478 | $6.07 | $1.25M | $100.6K | 5 | 2026-05-28 |
| GMED | Director | 15,578 | $86.15 | $1.34M | $0 | 5 | 2026-01-23 |
| NUVASIVE INC (NUVA) Delisted | Director | — | $39.75 | — | $0 | 8 | 2023-09-05 |
Recent Filings
99 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-03 | NDSN | Grant (A) | +84 | $25.0K | EDGAR |
| 2026-05-28 | MRVI | Grant (A) | +46,293 | $0 | EDGAR |
| 2026-05-04 | NDSN | Grant (A) | +87 | $25.1K | EDGAR |
| 2026-04-14 | GMED | Notice (144) | −30,000 | -$2.79M | EDGAR |
| 2026-02-03 | NDSN | Grant (A) | +91 | $25.0K | EDGAR |
| 2026-01-23 | GMED | Grant (A) | — | $0 | EDGAR |
| 2025-11-03 | NDSN | Grant (A) | +822 | $190.7K | EDGAR |
| 2025-06-18 | MRVI | Grant (A) | +89,139 | $192.5K | EDGAR |
| 2025-03-28 | GMED | Grant (A) | — | $0 | EDGAR |
| 2024-11-14 | MRVI | Buy (P) | +17,500 | $100.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.